| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000018419 |
| Receipt No. | R000021322 |
| Official scientific title of the study | Safety evaluation of laparoscopic radical hysterectomy for stages IA2-IB1 uterine cervical cancer. |
| Date of disclosure of the study information | 2015/07/31 |
| Last modified on | 2016/07/24 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Safety evaluation of laparoscopic radical hysterectomy for stages IA2-IB1 uterine cervical cancer. | |
| Title of the study (Brief title) | Safety evaluation of laparoscopic radical hysterectomy for early stage uterine cervical cancer. | |
| Region |
|
|
| Condition | ||
| Condition | Stages IA2-IB1 uterine cervical cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Safety evaluation of laparoscopic radical hysterectomy |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Phase I |
| Assessment | |
| Primary outcomes | 1) Intraoperative blood loss
2) Perioperative complications 3) Operative time |
| Key secondary outcomes | The number of hospitalization days |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Laparoscopic radical hysterectomy | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | Patients with preoperative stages IA2-IB1 uterine cervical cancer, who don't require fertility. | |||
| Key exclusion criteria | Patients who have operative risks and/or anesthetic risks. | |||
| Target sample size | 3 | |||
| Research contact person | |
| Name of lead principal investigator | Hiroshi Tatsumi |
| Organization | Kyoto Prefectural University of Medicine |
| Division name | Department of Obstetrics and Gynecology |
| Address | 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JAPAN |
| TEL | 075-251-5560 |
| htatsumi@koto.kpu-m.ac.jp | |
| Public contact | |
| Name of contact person | Hiroshi Tatsumi |
| Organization | Kyoto Prefectural University of Medicine |
| Division name | Department of Obstetrics and Gynecology |
| Address | 465 Kajii-cho, Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto 602-8566, JAPAN |
| TEL | 075-251-5560 |
| Homepage URL | |
| htatsumi@koto.kpu-m.ac.jp | |
| Sponsor | |
| Institute | Kyoto Prefectural University of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Kyoto Prefectural University of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 京都府立医科大学附属病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000021322 |